Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



Google+

At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.




Latest Member Blogs

Member
Total Posts: 1
6/14/2017
09:29PM
Member
Total Posts: 1
6/14/2017
02:18PM
Member
Total Posts: 1
6/13/2017
09:49AM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
Sarepta Therapeutics' (SRPT) Buy Rating Reaffirmed at Robert W. Baird - Week Herald

Sarepta Therapeutics' (SRPT) Buy Rating Reaffirmed at Robert W. Baird
Week Herald
Sarepta Therapeutics, Inc. (NASDAQ:SRPT)'s stock had its “buy” rating reaffirmed by analysts at Robert W. Baird in a research report issued to clients and investors on Tuesday. They presently have a $101.00 price target on the biotechnology company's ...

and more »
Biogen's (BIIB) “Buy” Rating Reiterated at Morgan Stanley - Week Herald

Biogen's (BIIB) “Buy” Rating Reiterated at Morgan Stanley
Week Herald
The biotechnology company reported $5.04 earnings per share for the quarter, topping the consensus estimate of $4.36 by $0.68. Biogen had a net margin of 28.10% and a return on equity of 37.42%. The firm had revenue of $3.08 billion for the quarter, ...

and more »
Exelixis, Inc. (EXEL) Sees Unusually-High Trading Volume Following Analyst Upgrade - StockNewsTimes

Exelixis, Inc. (EXEL) Sees Unusually-High Trading Volume Following Analyst Upgrade
StockNewsTimes
Legal & General Group Plc now owns 84,763 shares of the biotechnology company's stock valued at $1,834,000 after purchasing an additional 1,078 shares during the period. Aperio Group LLC raised its holdings in shares of Exelixis by 2.7% in the 2nd ...

and more »
Puma Biotechnology (PBYI) Seeing Increased Volatility in Session - Lenox Ledger (blog)

Puma Biotechnology (PBYI) Seeing Increased Volatility in Session
Lenox Ledger (blog)
Shares of Puma Biotechnology (PBYI) is moving on volatility today 0.52% or 0.65 from the open. The NASDAQ listed company saw a recent bid of 124.80 on 138764 volume. Top notch investors are usually adept at filtering through the constant financial ...

and more »
International Biotechnology Trust Plc (IBT.L) Momentum Alert as ATR Trends Higher - Business Review

International Biotechnology Trust Plc (IBT.L) Momentum Alert as ATR Trends Higher
Business Review
International Biotechnology Trust Plc (IBT.L) shares have seen the Average True Range climb higher over the past 10 sessions, indicating strong momentum potential and increased volatility. At the time of writing International Biotechnology Trust Plc's ...

and more »
International Biotechnology Trust Plc (IBT.L) Momentum Alert as ATR Trends Higher - Business Review

International Biotechnology Trust Plc (IBT.L) Momentum Alert as ATR Trends Higher
Business Review
International Biotechnology Trust Plc (IBT.L) shares have seen the Average True Range climb higher over the past 10 sessions, indicating strong momentum potential and increased volatility. At the time of writing International Biotechnology Trust Plc's ...

Analyst Research and Ratings: NCR Corporation (NCR), Puma Biotechnology, Inc. (PBYI) - Analyst Journal

Analyst Research and Ratings: NCR Corporation (NCR), Puma Biotechnology, Inc. (PBYI)
Analyst Journal
NCR Corporation (NYSE:NCR) tinted loss of -0.16% (-0.06 points) to US$37.48. The volume of 1.44 Million shares climbed up over an trading activity of 1.07 Million shares. EPS ratio determined by looking at last 12 month figures is 1.38. Over the same ...

Platinum Investment Management Ltd. Buys 5100 Shares of Prothena Corporation PLC (NASDAQ:PRTA) - Week Herald

Platinum Investment Management Ltd. Buys 5100 Shares of Prothena Corporation PLC (NASDAQ:PRTA)
Week Herald
The firm owned 66,500 shares of the biotechnology company's stock after purchasing an additional 5,100 shares during the quarter. Platinum Investment Management Ltd. owned approximately 0.17% of Prothena Corporation PLC worth $3,598,000 as of its ...

and more »
Seattle Genetics' (SGEN) “Hold” Rating Reaffirmed at SunTrust Banks, Inc. - StockNewsTimes

Seattle Genetics' (SGEN) “Hold” Rating Reaffirmed at SunTrust Banks, Inc.
StockNewsTimes
They currently have a $45.00 price target on the biotechnology company's stock. SunTrust Banks, Inc.'s price objective indicates a potential downside of 28.45% from the company's previous close. SGEN has been the subject of a number of other research ...

and more »
Critical Review: United Therapeutics Corporation (NASDAQ:UTHR) versus The Competition - TrueBlueTribune

Critical Review: United Therapeutics Corporation (NASDAQ:UTHR) versus The Competition
TrueBlueTribune
United Therapeutics Corporation (NASDAQ: UTHR) is one of 197 public companies in the “Biotechnology & Medical Research” industry, but how does it compare to its competitors? We will compare United Therapeutics Corporation to similar companies ...

and more »